Transcription of European Paediatric Formulation Initiative (EuPFi
{{id}} {{{paragraph}}}
Example: bankruptcy
European Paediatric Formulation Initiative (EuPFi
European Paediatric Formulation Initiative (EuPFi). The 4th Annual Conference of the EuPFI was held in Prague in September 2012. There were 69 abstracts (including oral presentations poster presentations). The abstracts of those presentations are listed below. Poster Abstract tile Authors Contact details of presenting no. author 2 #2 Minimised tablet sizes: Technical Jessica Soto, Peter feasibility compared to adult s tablet Kuehl, Arnaud Mauler, formulations Gesine Winzenburg, and Sabine Desset-Brethes 3 #3 Development of a pediatric Denis Larrouture, Gilles treatment against sickle cell disease lemagnen, Pascal Millet, crisis Steve Amoussou Guenou, Luc Grislain, and Pascale Gueroult 4 #4 Exploring the acceptability of Karen Mooney, James C. Paediatric microneedle-mediated Mcelnay, and Ryan F.
Formulating Better Medicines for Children microspheres 35 #35 the impact of the european paediatric regulation on authorised medicines for children – uk
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
DEVELOPMENT OF PAEDIATRIC MEDICINES:, DEVELOPMENT OF PAEDIATRIC MEDICINES: PHARMACEUTICAL DEVELOPMENT. POINTS, PHARMACEUTICAL, DEVELOPMENT OF PAEDIATRIC MEDICINES: POINTS, Development of paediatric medicines: points to consider in pharmaceutical development, Position Paediatric Age Categories to, Of paediatric development, PANADOL, Paediatric, Medicines, EU regulatory framework and the role, 2. qualitative and quantitative composition